Log in
NYSE:ADNT

Adient Stock Forecast, Price & News

$16.31
-0.34 (-2.04 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$15.90
Now: $16.31
$16.58
50-Day Range
$15.30
MA: $17.54
$18.68
52-Week Range
$5.90
Now: $16.31
$29.27
Volume991,575 shs
Average Volume1.42 million shs
Market Capitalization$1.53 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.39
Adient plc designs, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. It operates through three segments: Seating, Seat Structures and Mechanisms (SS&M), and Interiors. The Seating segment produces seat systems for automotive and other mobility applications, as well as various components of seat systems, including foams, trims, and fabrics. The SS&M segment produces seat structures and mechanisms for inclusion in seat systems that are produced by others. The Interiors segment produces instrument panels, floor consoles, door panels, overhead consoles, cockpit systems, decorative trims, and other products. The company operates in the Americas, Europe, China, and internationally. Adient plc was incorporated in 2016 and is based in Dublin, Ireland.
Read More
Adient logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.54 out of 5 stars


Industry, Sector and Symbol

Industry Motor vehicle parts & accessories
Sub-IndustryN/A
CUSIPN/A
Phone734-254-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$16.53 billion
Cash Flow$4.99 per share
Book Value$23.38 per share

Profitability

Net Income$-491,000,000.00

Miscellaneous

Employees83,000
Market Cap$1.53 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$16.31
-0.34 (-2.04 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ADNT News and Ratings via Email

Sign-up to receive the latest news and ratings for ADNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Adient (NYSE:ADNT) Frequently Asked Questions

How has Adient's stock price been impacted by COVID-19?

Adient's stock was trading at $16.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ADNT stock has decreased by 0.9% and is now trading at $16.31.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Adient?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Adient in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Adient
.

When is Adient's next earnings date?

Adient is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Adient
.

How were Adient's earnings last quarter?

Adient PLC (NYSE:ADNT) released its quarterly earnings data on Thursday, August, 6th. The company reported ($2.78) earnings per share for the quarter, missing the Zacks' consensus estimate of ($2.08) by $0.70. The company earned $1.63 billion during the quarter, compared to the consensus estimate of $1.64 billion. Adient had a negative return on equity of 2.80% and a negative net margin of 3.96%. The firm's quarterly revenue was down 61.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.38 earnings per share.
View Adient's earnings history
.

What guidance has Adient issued on next quarter's earnings?

Adient issued an update on its fourth quarter 2020 Pre-Market earnings guidance on Thursday, August, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.3-3.5 billion, compared to the consensus revenue estimate of $3.31 billion.

What price target have analysts set for ADNT?

11 brokers have issued 12-month price targets for Adient's stock. Their forecasts range from $13.00 to $28.00. On average, they anticipate Adient's share price to reach $21.18 in the next year. This suggests a possible upside of 29.9% from the stock's current price.
View analysts' price targets for Adient
.

Are investors shorting Adient?

Adient saw a increase in short interest during the month of August. As of August 14th, there was short interest totaling 3,960,000 shares, an increase of 14.5% from the July 30th total of 3,460,000 shares. Based on an average trading volume of 1,080,000 shares, the days-to-cover ratio is presently 3.7 days. Approximately 4.3% of the shares of the company are short sold.
View Adient's Short Interest
.

Who are some of Adient's key competitors?

What other stocks do shareholders of Adient own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), Exxon Mobil (XOM), AbbVie (ABBV), NVIDIA (NVDA), Intel (INTC), Cisco Systems (CSCO), Pfizer (PFE), Ford Motor (F) and Johnson & Johnson (JNJ).

Who are Adient's key executives?

Adient's management team includes the following people:
  • Mr. Jeffrey M. Stafeil, Exec. VP & CFO (Age 49)
  • Ms. Cathleen A. Ebacher, VP, Gen. Counsel & Sec. (Age 57)
  • Mr. Douglas G. Del Grosso, Pres, CEO & Director (Age 57)
  • Mr. Byron S. Foster, Exec. VP (Age 51)
  • Mr. Mark Oswald, VP of Investor Relations

What is Adient's stock symbol?

Adient trades on the New York Stock Exchange (NYSE) under the ticker symbol "ADNT."

Who are Adient's major shareholders?

Adient's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Lyrical Asset Management LP (5.55%), Vanguard Group Inc. (3.55%), Goldman Sachs Group Inc. (3.05%), Prudential Financial Inc. (2.38%), Letko Brosseau & Associates Inc. (2.38%) and Ninety One UK Ltd (2.28%). Company insiders that own Adient stock include Gregory Scott Smith, Jeffrey Stafeil and Jerome J Dorlack.
View institutional ownership trends for Adient
.

Which major investors are selling Adient stock?

ADNT stock was sold by a variety of institutional investors in the last quarter, including Ninety One UK Ltd, FMR LLC, Engineers Gate Manager LP, Vanguard Group Inc., Point72 Asset Management L.P., Letko Brosseau & Associates Inc., Charles Schwab Investment Management Inc., and SG Americas Securities LLC.
View insider buying and selling activity for Adient
.

Which major investors are buying Adient stock?

ADNT stock was acquired by a variety of institutional investors in the last quarter, including Lyrical Asset Management LP, Goldman Sachs Group Inc., Impala Asset Management LLC, Hudson Bay Capital Management LP, Prudential Financial Inc., Bridgeway Capital Management Inc., Alyeska Investment Group L.P., and Brookfield Asset Management Inc.. Company insiders that have bought Adient stock in the last two years include Gregory Scott Smith, Jeffrey Stafeil, and Jerome J Dorlack.
View insider buying and selling activity for Adient
.

How do I buy shares of Adient?

Shares of ADNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Adient's stock price today?

One share of ADNT stock can currently be purchased for approximately $16.31.

How big of a company is Adient?

Adient has a market capitalization of $1.53 billion and generates $16.53 billion in revenue each year. The company earns $-491,000,000.00 in net income (profit) each year or $1.63 on an earnings per share basis. Adient employs 83,000 workers across the globe.

What is Adient's official website?

The official website for Adient is www.adient.com.

How can I contact Adient?

Adient's mailing address is 49200 Halyard Drive, Plymouth MI, 48170. The company can be reached via phone at 734-254-5000.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.